Hemo Organic Ltd Financials
Company Logo

Hemo Organic Ltd Financial Statement

Hemo Organic Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue2.50
Operating Expense2.27
Net Profit0.37
Net Profit Margin14.80
Earning Per Share1.08
EBIDTA0.37
Effective Tax RateTBA

Hemo Organic Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual0.02
Operating Expenses Annual0.27
Operating Profit Annual-0.25
Interest Annual0.02
DepreciationTBA
Net Profit Annual-0.26
Tax AnnualTBA

Hemo Organic Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.12
Cash Flow from Operations-1.19
Cash Flow from InvestingTBA
Cash Flow from Financing1.20
Cash Flow at the End0.13

Hemo Organic Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)-1,200
PBIT Margin (%)-1,200
PBT Margin (%)58,800
Net PROFIT Margin (%)-1,300
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-52
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)0.04

Hemo Organic Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.00
Total Current Assets Annual0.92
Non Current Assets Annual0.14
Total Shareholders Funds Annual-0.32
Total Assets Annual1.06

Hemo Organic Ltd Earning Calls

No Data Availabe

FAQS on Hemo Organic Ltd Financials

As of Jul 6, 2025, Hemo Organic Ltd has a market capitalization of 3.11 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Hemo Organic Ltd is with a debt-to-equity ratio of -9.77.

In FY 2024 , Hemo Organic Ltd recorded a total revenue of approximately 2.41 Cr marking a significant milestone in the company's financial performance.

Hemo Organic Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and Infinity% annually, respectively..

Hemo Organic Ltd's current PE ratio is 19.44.

Hemo Organic Ltd's ROCE averaged 105.5% from the FY ending March 2023 to 2025, with a median of 1.9%. It peaked at 341.3% in March 2023, reflecting strong capital efficiency over the period..

Hemo Organic Ltd's latest EBIT is Rs. 0.03 Cr, surpassing the average EBIT of Rs. -0.09 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions